Hubei Guangji Pharmaceutical Co Ltd (000952) — Financial Flexibility Index
Hubei Guangji Pharmaceutical Co Ltd (000952) has a Financial Flexibility Index of 0.02x as of September 2025. Free cash flow of CN¥31.05 Million (operating CF CN¥22.38 Million minus capex CN¥8.67 Million) represents 0% of total liabilities (CN¥1.62 Billion). Also explore Hubei Guangji Pharmaceutical Co Ltd equity growth rate to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Hubei Guangji Pharmaceutical Co Ltd Financial Flexibility Index (1998–2024)
Historical Financial Flexibility Index trend for Hubei Guangji Pharmaceutical Co Ltd across 27 annual periods. Check 000952 strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Hubei Guangji Pharmaceutical Co Ltd (1998–2024)
Year-by-year free cash flow to debt coverage for Hubei Guangji Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see 000952 company net worth.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.09x | CN¥155.59 Million | CN¥655.36K | CN¥1.72 Billion | ▼ -64.4% |
| 2023 | 0.25x | CN¥417.17 Million | CN¥-148.96 Million | CN¥1.64 Billion | ▲ +0.1% |
| 2022 | 0.25x | CN¥248.79 Million | CN¥45.08 Million | CN¥977.25 Million | ▼ -11.7% |
| 2021 | 0.29x | CN¥172.51 Million | CN¥75.91 Million | CN¥598.09 Million | ▼ -18.5% |
| 2020 | 0.35x | CN¥217.27 Million | CN¥119.38 Million | CN¥613.75 Million | ▲ +7.6% |
| 2019 | 0.33x | CN¥263.96 Million | CN¥144.20 Million | CN¥802.21 Million | ▼ -13.2% |
| 2018 | 0.38x | CN¥307.97 Million | CN¥231.44 Million | CN¥812.33 Million | ▲ +28.0% |
| 2017 | 0.30x | CN¥259.74 Million | CN¥178.83 Million | CN¥876.65 Million | ▲ +3.1% |
| 2016 | 0.29x | CN¥280.02 Million | CN¥167.07 Million | CN¥974.70 Million | ▲ +315.2% |
| 2015 | 0.07x | CN¥76.59 Million | CN¥-33.35 Million | CN¥1.11 Billion | ▲ +273.8% |
| 2014 | 0.02x | CN¥19.94 Million | CN¥-74.69 Million | CN¥1.08 Billion | ▼ -89.6% |
| 2013 | 0.18x | CN¥145.20 Million | CN¥95.16 Million | CN¥816.78 Million | ▼ -37.2% |
| 2012 | 0.28x | CN¥225.48 Million | CN¥108.02 Million | CN¥795.93 Million | ▼ -35.6% |
| 2011 | 0.44x | CN¥282.84 Million | CN¥81.88 Million | CN¥643.07 Million | ▲ +24.4% |
| 2010 | 0.35x | CN¥192.74 Million | CN¥77.18 Million | CN¥545.06 Million | ▲ +37.1% |
| 2009 | 0.26x | CN¥125.58 Million | CN¥-24.35 Million | CN¥486.93 Million | ▼ -76.8% |
| 2008 | 1.11x | CN¥440.46 Million | CN¥220.70 Million | CN¥395.78 Million | ▼ -4.8% |
| 2007 | 1.17x | CN¥380.92 Million | CN¥331.98 Million | CN¥325.76 Million | ▲ +148.4% |
| 2006 | 0.47x | CN¥144.68 Million | CN¥125.95 Million | CN¥307.34 Million | ▲ +106.4% |
| 2005 | 0.23x | CN¥79.98 Million | CN¥54.14 Million | CN¥350.68 Million | ▲ +100.3% |
| 2004 | 0.11x | CN¥44.27 Million | CN¥-3.32 Million | CN¥388.76 Million | ▼ -20.3% |
| 2003 | 0.14x | CN¥50.34 Million | CN¥-15.40 Million | CN¥352.38 Million | ▼ -64.7% |
| 2002 | 0.40x | CN¥126.72 Million | CN¥76.20 Million | CN¥313.05 Million | ▲ +355.4% |
| 2001 | 0.09x | CN¥24.44 Million | CN¥-22.40 Million | CN¥274.96 Million | ▼ -76.5% |
| 2000 | 0.38x | CN¥73.67 Million | CN¥48.57 Million | CN¥194.67 Million | ▼ -63.0% |
| 1999 | 1.02x | CN¥204.15 Million | CN¥68.57 Million | CN¥199.49 Million | ▲ +1650.4% |
| 1998 | -0.07x | CN¥-12.33 Million | CN¥-15.29 Million | CN¥186.80 Million | — |